Abstract

BackgroundIntimal injury rapidly activates TGFβ and enhances vascular repair by the growth of endothelial (EC) and vascular smooth muscle cells (VSMC). The response to the TGFβ family of growth factors can be modified by BAMBI (BMP, Activin, Membrane Bound Inhibitor) acting as a non-signaling, competitive antagonist of TGFβ type I receptors such as ALK 1 and 5. In vivo the effect of BAMBI will depend on its cell-specific expression and of that of the ALK type receptors. We recently reported EC restricted BAMBI expression and genetic elimination of BAMBI resulting in an in vitro and in vivo phenotype characterized by endothelial activation and proliferation involving alternative pathway activation by TGFβ through ALK 1.Methodology/Principal FindingsTo test the hypothesis that BAMBI modulates arterial response to injury via its effects on endothelial repair and arterial wall neovascularization we used a model of femoral arterial denudation injury in wild type (WT) and BAMBI−/− mice. Arterial response was evaluated at 2 and 4 weeks after luminal endothelial denudation of femoral arteries. The BAMBI−/− genotype mice showed accelerated luminal endothelial repair at 2 weeks and a highly unusual increase in arterial wall neovascularization compared to WT mice. The exuberant intimal and medial neovessel formation with BAMBI−/− genotype was also associated with significant red blood cell extravasation. The bleeding into the neointima at 2 weeks transiently increased it’s area in the BAMBI−/−genotype despite the faster luminal endothelial repair in this group. Vascular smooth muscle cells were decreased at 2 weeks in BAMBI−/− mice, but comparable to wild type at 4 weeks.Conclusions/SignificanceThe absence of BAMBI results in a highly unusual surge in arterial wall neovascularization that surprisingly mimiks features of intra-plaque hemorrhage of advanced atheroma in a mechanical injury model. This suggests important effects of BAMBI on arterial EC homeostasis that need to be further studied in a model of inflammatory atherosclerosis.

Highlights

  • Arterial injury induces a rapid activation of Transforming Growth Factor b (TGFb) signaling in the arterial wall

  • The novel molecule BAMBI (BMP, Activin, Membrane Bound Inhibitor) in turn modifies the cellular response to the TGFb family of growth factors by acting as a non-signaling, competitive antagonist of TGFb type I receptors such as ALK 1 and 5 [7,8]

  • We showed that in endothelial cell (EC) this phenotype could be mechanistically attributed to enhanced alternative TGFb signaling through ALK 1 and ERK2 and SMAD 1/5 activation after BAMBI elimination [9]

Read more

Summary

Introduction

Arterial injury induces a rapid activation of Transforming Growth Factor b (TGFb) signaling in the arterial wall. Histo-morphometric analysis of arteries at 2 and 4 weeks after endothelial denudation revealed increased neointima formation without a change in media or total vessel size in the BAMBI2/2 compared to WT mice; resulting in a significantly greater intima/media ratio at 2 weeks (Figure 1A– C).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.